Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-02-10 @ 1:10 AM
Study NCT ID:
NCT01934894
Status:
TERMINATED
Last Update Posted:
2017-07-02
First Post:
2013-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
Sponsor:
SCRI Development Innovations, LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer With Intracranial Metastases | View |